Finally, after a series of screening and verification tests, we identified a threonine and tyrosine kinase (TTK) gene that can indeed promote tumor progression and predict the prognosis of BC, and we revealed that TTK may be a potential indicator of the changes in the TME in BC. The gene discussed is TTK; the disease is breast cancer.